Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine levels in shed blood and plasma after local analgesia in total knee replacement
NL-OMON34159Active, not recruiting
- Sponsor
- Haaglanden Medical Centre
- Start
- Mar 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ropivacaine in osteoarthritis (OA), sponsored by Haaglanden Medical Centre. Primary endpoints: Ropivacaine concentration in patient serum and Ropivacaine concentration in shed blood collected with Bellovac ABT. Started Mar 2011; status: active, not recruiting.
02
Drugs
ropivacaine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON34159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34159.